EE200200152A - Antikeha-värvaine konjugaadid angiogeneesi sihtstruktuuridega seondumiseks kasvajate äärealade intraoperatiivseks visualiseerimiseks - Google Patents

Antikeha-värvaine konjugaadid angiogeneesi sihtstruktuuridega seondumiseks kasvajate äärealade intraoperatiivseks visualiseerimiseks

Info

Publication number
EE200200152A
EE200200152A EEP200200152A EEP200200152A EE200200152A EE 200200152 A EE200200152 A EE 200200152A EE P200200152 A EEP200200152 A EE P200200152A EE P200200152 A EEP200200152 A EE P200200152A EE 200200152 A EE200200152 A EE 200200152A
Authority
EE
Estonia
Prior art keywords
antibody
binding
structures
dye conjugates
intraoperative visualization
Prior art date
Application number
EEP200200152A
Other languages
English (en)
Inventor
Schirner Michael
Licha Kai
Dinkelborg Ludger
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7924318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200200152(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200200152A publication Critical patent/EE200200152A/et
Publication of EE05176B1 publication Critical patent/EE05176B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0039—Coumarin dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EEP200200152A 1999-09-24 2000-08-19 Antikeha-v„rvaine konjugaadid angiogeneesi sihtstruktuuridega seondumiseks kasvajate „„realade intraoperatiivseks visualiseerimiseks EE05176B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947559A DE19947559A1 (de) 1999-09-24 1999-09-24 Antikörper-Farbstoffkonjugate gegen Zielstrukturen der Angiogenese zur intraoperativen Tumorranddarstellung
PCT/EP2000/008121 WO2001023005A1 (de) 1999-09-24 2000-08-19 Antikörper-farbstoffkonjugate gegen zielstrukturen der angiogenese zur intraoperativen tumorranddarstellung

Publications (2)

Publication Number Publication Date
EE200200152A true EE200200152A (et) 2003-04-15
EE05176B1 EE05176B1 (et) 2009-06-15

Family

ID=7924318

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200152A EE05176B1 (et) 1999-09-24 2000-08-19 Antikeha-v„rvaine konjugaadid angiogeneesi sihtstruktuuridega seondumiseks kasvajate „„realade intraoperatiivseks visualiseerimiseks

Country Status (23)

Country Link
EP (2) EP1532988A3 (et)
JP (1) JP2003510294A (et)
KR (2) KR20070087232A (et)
CN (1) CN1269530C (et)
AU (1) AU779026B2 (et)
BG (1) BG65682B1 (et)
BR (1) BR0014192A (et)
CA (1) CA2385593A1 (et)
CZ (1) CZ2002991A3 (et)
DE (1) DE19947559A1 (et)
EE (1) EE05176B1 (et)
HK (1) HK1050491A1 (et)
HU (1) HUP0202625A2 (et)
IL (2) IL148405A0 (et)
MX (1) MXPA02002639A (et)
NO (1) NO20021441L (et)
NZ (1) NZ517944A (et)
RO (1) RO121598B1 (et)
RU (1) RU2002109237A (et)
SK (1) SK3972002A3 (et)
WO (1) WO2001023005A1 (et)
YU (1) YU20702A (et)
ZA (1) ZA200203225B (et)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4243201A (en) 2000-02-24 2001-09-03 Eidgenoess Tech Hochschule Antibody specific for the ed-b domain of fibronectin, conjugates comprising saidantibody, and their use for the detection and treatment of angiogenesis
US6440389B1 (en) * 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
AT413487B (de) 2002-08-12 2006-03-15 Igeneon Krebs Immuntherapie Verwendung von antikörpern gegen ein tumor-assoziiertes antigen
NO20034351D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av endometrose
EP1816475A1 (en) * 2004-07-22 2007-08-08 Bayer Schering Pharma Aktiengesellschaft Use of cyanine dyes for the diagnosis of disease associated with angiogenesis
EP1679082A1 (en) * 2005-01-07 2006-07-12 Schering AG Use of cyanine dyes for the diagnosis of proliferative diseases
US20120041305A1 (en) * 2009-04-21 2012-02-16 The University Of Utah Research Foundation Light-emitting dye for intraoperative imaging or sentinel lymph node biopsy
EP3493855A4 (en) * 2016-08-02 2020-04-01 ISI Life Sciences, Inc. METHOD FOR DETECTION OF CANCER CELLS.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341223A (en) * 1981-02-04 1982-07-27 Lutz Lauralee A Fluoresceable composition and method of determining fluid flow
CN1162184C (zh) * 1994-07-11 2004-08-18 德克萨斯州立大学董事会 用于脉管系统特异性凝血的组合物及其应用
TWI259837B (en) * 1998-05-11 2006-08-11 Eidgenossische Tech Hochscule Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis

Also Published As

Publication number Publication date
KR20070087232A (ko) 2007-08-27
IL148405A0 (en) 2002-09-12
NO20021441L (no) 2002-05-15
DE19947559A1 (de) 2001-04-19
AU6702600A (en) 2001-04-30
HK1050491A1 (en) 2003-06-27
RU2002109237A (ru) 2003-11-27
CN1376074A (zh) 2002-10-23
KR20020039349A (ko) 2002-05-25
EP1532988A3 (de) 2008-09-17
SK3972002A3 (en) 2002-09-10
WO2001023005A1 (de) 2001-04-05
EE05176B1 (et) 2009-06-15
NZ517944A (en) 2004-06-25
BR0014192A (pt) 2002-05-21
BG65682B1 (bg) 2009-06-30
EP1214099A1 (de) 2002-06-19
BG106528A (bg) 2002-12-29
MXPA02002639A (es) 2002-07-30
EP1532988A2 (de) 2005-05-25
JP2003510294A (ja) 2003-03-18
YU20702A (sh) 2005-06-10
ZA200203225B (en) 2003-07-23
NO20021441D0 (no) 2002-03-22
CN1269530C (zh) 2006-08-16
CA2385593A1 (en) 2001-04-05
HUP0202625A2 (en) 2002-12-28
KR100832937B1 (ko) 2008-05-27
CZ2002991A3 (cs) 2002-06-12
RO121598B1 (ro) 2007-12-28
IL148405A (en) 2009-06-15
PL354027A1 (en) 2003-12-15
AU779026B2 (en) 2005-01-06

Similar Documents

Publication Publication Date Title
NO20014105D0 (no) Texanderivater for malrettet kreftterapi
PT1200065E (pt) Composicao de ovulos intravaginais de clindamicina
DE60002795D1 (de) Bindermittelzusammensetzung
EE200200673A (et) Kinasoliini derivaadid kasvajate raviks
NO20022048D0 (no) Brönnfôring for reparasjoner
NO20021400D0 (no) Terapeutiske konazolinderivater
NO20020037D0 (no) Fremgangsmåter for å unngå vektökning
AU2291001A (en) Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
NO20014607D0 (no) Sammensetninger til forbedring av fertilitet
AR027890A1 (es) Formulaciones para verter
EE200200152A (et) Antikeha-värvaine konjugaadid angiogeneesi sihtstruktuuridega seondumiseks kasvajate äärealade intraoperatiivseks visualiseerimiseks
AU2002214576A1 (en) Genes related to development of refractory prostate cancer
NO974972D0 (no) Fremgangsmåte for å hindre brystcancer
ATA175199A (de) Hydraulische betätigungsanordnung
ATA198399A (de) Hydraulische betätigungsanordnung
NO20021658L (no) Asfaltenhemmere
NO20023971D0 (no) Hormonterapi ved brystcancer
NO20020153L (no) Bruk av interleukin-18 inhibitorer for å hemme tumormetastase
PT1194426E (pt) Derivados de benzofurano
PT1175417E (pt) Compostos substituidos de benzolactamas
ATA191899A (de) Hydraulische betätigungsanordnung
FR2799341B3 (fr) Structure de secateur horticole perfectionne
FI990432A (fi) Kaksiviiraformeri
AU1609001A (en) Use of egf genistein to prevent development of egf-receptor expressing cancers
AR027857A1 (es) Nucleo absorbente mejorado

Legal Events

Date Code Title Description
MM4A Lapsed by not paying the annual fees

Effective date: 20090819